Verona Pharma
NasdaqGM:VRNA
$ 106,91
$0,00 (0,00%)
106,91 $
$0,00 (0,00%)
End-of-day quote: 10/07/2025

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

This stock is no longer listed on the stock exchange.

$-2,08
Earnings Per Share
$0,49
Revenue Per Share
93,89%
Gross Margin %
$9,22 B
Market Cap
$0,23 B
Long-Term Debt
Earnings Per Share
$-2,08
Revenue Per Share
$0,49
Gross Margin %
93,89%
Market Cap
$9,22 B
Long-Term Debt
$0,23 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017
EPS Earnings Per Share $-2,08 $-0,09 $-1,03 $-0,96 $-2,00 $-3,13 $-1,98 $-3,28
Earnings Earnings $-176,76M $-7,81M $-81,36M $-57,96M $-115,86M $-41,22M $-26,08M $-43,07M
RPS Revenue Per Share $0,49 $0,00 $0,01 $0,67 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $41,93M $0,00M $0,46M $40,58M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $-121,20M $0,00M $0,00M $-33,76M $0,00M $-44,79M $-23,08M $-27,97M
FCF Free Cash Flow $-121,77M $0,00M $0,00M $0,00M $0,00M $-44,84M $-23,10M $-27,99M
OM Operating Margin 0,00% 0,00% 0,00% -144,21% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 93,89% 0,00% 24,45% 100,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $-1,51 $-0,63 $-0,91 $-0,56 $-1,37 $-3,26 $-1,78 $-2,58
LT Debt Long-Term Debt $225,76M $48,37M $9,77M $4,87M $4,64M N/A N/A N/A
Sha. Stocks 84,98M 86,83M 78,99M 60,37M 57,93M 13,17M 13,17M 13,13M
×